RUPATADINE EG 10 mg, tablet 15 tablets
Active ingredients: Rupatadine fumarate, Rupatadine
Commercialized according to BDPMDispensing in France: Prescription only
Tablet15 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RUPATADINE EG 10 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 15 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Sept 2017
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66167509CIP73007725CIP133400930077252Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RUPATADINEcomprimé | 10 mg · un comprimé | FT |
| FUMARATE DE RUPATADINEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.